Artiva Biotherapeutics, Inc.: Form 8-K, filed Dec 12, 2025

Filed with the SEC on Dec 12, 2025 and accepted by EDGAR at Dec 12, 2025, 17:23 ET.

Share this page

Link

X
Threads
Bluesky
LinkedIn
Facebook
Reddit
WhatsApp
Telegram
Pinterest
Hacker News
Email

Story card, 1080 × 1920

Items reported

Item 5.02 Departure or appointment of officers or directors

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Source: SEC EDGAR, the filing index for accession 0001193125-25-317784. Last ingested by Listed: Nov 10, 2026, 01:58 ET. Listed shows no prices and gives no investment advice.